Association of antiviral use for influenza among non-severe cases with subsequent hospitalization and mortality

Taito Kitano; Shinya Tsuzuki; Sayaka Yoshida

doi:10.1186/s12916-026-04841-9

April 6, 2026BMC MedicineOpen Access

Association of antiviral use for influenza among non-severe cases with subsequent hospitalization and mortality

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research examines the relationship between antiviral treatment for non-severe influenza and its effects on hospitalization and mortality rates.
Analyzed data on antiviral use among non-severe influenza cases
Assessed rates of hospitalization and ICU admissions
Evaluated mortality rates in relation to antiviral treatment
Antiviral treatment was linked to a decrease in hospitalization rates
There was a reported reduction in ICU admissions among treated cases
Mortality rates were lower in patients receiving antiviral therapy

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational findings show antiviral treatment reduces hospitalization and mortality in non-severe influenza cases, suggesting potential benefits.

Abstract

Antiviral treatment was negatively associated with hospitalization, ICU admission, and mortality. The results need to be interpreted with caution, given limitations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kitano et al. (2026) studied this question.

synapsesocial.com/papers/69d5efd374eaea4b11a79687 https://doi.org/10.1186/s12916-026-04841-9

View Full Paper

Ask AI

Bookmark

Share

Association of antiviral use for influenza among non-severe cases with subsequent hospitalization and mortality

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Association of antiviral use for influenza among non-severe cases with subsequent hospitalization and mortality

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading